Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
Breast Cancer Research and Treatment, 05/25/2012
Tang J et al. – The findings suggest that decreased expression of ULK1 is associated with breast cancer progression, together with closely related to decreased autophagic capacity. ULK1 also may be used as a novel prognostic biomarker for breast cancer patients.